Ruxolitinib was found to be a “safe and effective” treatment for chronic graft-versus-host disease (cGVHD) in a real-world setting, demonstrating “remission rates comparable to clinical trials,” according to a recent study published in Transfusion and Apheresis Science. A team of researchers from Turkey performed the study to evaluate the medication’s efficacy in patients experiencing the “significant challenges,” including poor prognosis and increased morbidity, which follow a diagnosis of cGVHD. ...
GVHD
Explore the most recent clinical developments in graft-versus-host disease (GVHD). Cancer Nursing Today provides up-to-date coverage of biomarkers for GVHD, chronic GVHD flares during immunosuppressive therapy, and more. From disease prevention in pediatric patients to drug evaluation for chronic GVHD, learn more about the evolution of GVHD care and research.
Advertisement
Partially hydrolyzed guar gum, a soluble dietary fiber obtained from guar beans, was evaluated due to its butyrate content.
The Lee Symptom Scale for skin sclerosis was informed by patient interviews and feedback.
Patients with cGVHD appreciate the opportunity to connect with other individuals also navigating a cGVHD diagnosis.
Access to a multidisciplinary GVHD clinic with telehealth abilities improved care for patients with acute and chronic GVHD.
Learn how oral dysbiosis correlates with exacerbated cGVHD in patients after receiving hematopoietic cell transplantation.
Novel agents recently approved by the FDA showed promising responses when combined for treating refractory cGVHD.
The study highlights the need for improved patient education and provider communication on early symptoms of cGVHD.
Research presented at ASH 2024 highlighted the importance of absolute monocyte counts after transplant.
Research presented at ASH 2024 showed that adding budesonide didn’t compromise immunologic recovery and transplant ...
A study presented at the 2024 ASH Annual Meeting suggests that a certain test may predict GI issues caused by GVHD.
Advertisement
Trending
Studying for certification tests can be intimidating. Here are some essential tips to help you do your best.
These tips are important resources for oncology nurses who are recent graduates and experienced nurses new to this specialty.
With the shift in cancer care to the ambulatory care setting, a dedicated oncology nurse educator is a key asset to nurses.
Gastroparesis occurs in 60% of patients with advanced pancreatic cancer, and is frequently overlooked in upper GI tumors.
More unique, non-traditional jobs are emerging for oncology nurses to consider outside traditional positions.
Alkaline phosphatase may serve as a discriminating marker in detecting bone lesions in patients with multiple myeloma.
Advertisement
Expert Contributor
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®, is the owner of beyond Oncology Education, LLC.
Advertisement
Latest News
Theresa Brown, RN, shares why it's key to educate patients on the complexity of medical decisions and risk-benefit analyses.
The study explored the characteristics of sick role adaptation in colorectal cancer and its differences across age groups.
A recent survey provides key insights into patient experiences with MIBC treatment and diagnosis over the past decade.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.